C51.9

Clinical Causes: Human papillomavirus (HPV) infection, especially high-risk types Age-related factors, with higher incidence in older women Smoking, which increases the risk of cellular changes Chronic vulvar conditions such as lichen sclerosus or vulvar dystrophy History of vulvar intraepithelial neoplasia (VIN), pre-cancerous changes Immunosuppression, including conditions like HIV/AIDS or post-organ transplant Genetic predisposition and family history of gynecologic cancers

Key Symptoms: Persistent vulvar itching, soreness, or pain A noticeable lump, growth, or sore on the vulva that doesn’t heal Changes in skin color, such as white, red, or dark patches Bleeding or unusual discharge from the vulva A lump or swelling in the groin or vulvar area discomfort during urination or sexual activity Skin ulcers or tenderness in the affected area

Diagnosis Path: Diagnosis typically involves a combination of medical history review, physical examination, and laboratory tests. A healthcare provider may perform a biopsy of the suspicious lesion to determine if it is malignant. Additional imaging tests, such as ultrasound, CT scans, or MRI, can help assess the extent of the disease and whether it has spread to nearby tissues or lymph nodes.

Treatment Protocols: Treatment options depend on the stage and extent of the cancer, as well as the patient's overall health. Common approaches include: - Surgical removal of the tumor, which may range from local excision to more extensive vulvectomy - Radiation therapy to target cancer cells and reduce tumor size - Chemotherapy, particularly in cases where the cancer has spread beyond the vulva - Targeted therapy and immunotherapy, emerging options for specific cases Follow-up care is crucial to monitor for recurrence and manage any side effects of treatment.